Creates provisions relating to 340B drugs

This bill prohibits health insurers and pharmacy benefit managers from discriminating against hospitals and clinics participating in the federal 340B drug program. It specifically bans them from paying lower reimbursements for 340B drugs than other pharmacies, applying different requirements (like fees or network restrictions), or refusing to cover 340B drugs. Violations can trigger $5,000 daily penalties enforced by the Insurance Department. The law applies to safety-net hospitals and clinics that buy drugs at discounted federal rates under the 340B program.